Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2023-12-18 Capital/Financing Update
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Enterprise Licence Order Received for 3Dicom R&D Software 3 pages 152.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 December 2023 from Singular Health Group Ltd. It discusses a new enterprise license order for their 3Dicom R&D software, appointment of a sales partner in India, and market opportunities. The content is focused on business updates, partnerships, and product adoption rather than financial results, regulatory filings, or detailed financial statements. There is no indication of quarterly or annual financial data, audit information, or management discussion of financial results. The document is a corporate announcement about commercial developments and partnerships, typical of a Capital/Financing Update or general business update. Given the nature of the content and the absence of financial report data, the best fitting category is Capital/Financing Update (CAP). The document length (6680 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2023-12-18 English
Appendix 3Y - Change of Director's Interest Notice x 3 10 pages 25.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y' and is described as a 'Change of Director's Interest Notice.' It references ASX listing rule 3.19A.2 and section 205G of the Corporations Act, which relate to disclosures of directors' personal share transactions. The content details changes in securities holdings by directors, including allotments and disposals of shares and options. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure of insider transactions by directors, fitting the definition of Director's Dealing filings.
2023-12-13 English
Notification regarding unquoted securities - SHG 10 pages 37.6KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed notification about the issue of unquoted equity securities by Singular Health Group Ltd. It includes specifics about the types and numbers of securities issued, dates, consideration, and references to related shareholder approvals and previous announcements. The content focuses on the issuance of new securities, including performance rights and unlisted options, and mentions compliance with ASX listing rules. There is no financial performance data, earnings information, or management discussion. The document is clearly an announcement related to capital changes, specifically the issuance of new securities. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication notice but a substantive notification of capital changes.
2023-12-10 English
Singular Receives Commitment for $850,000 from CG1 Ventures 2 pages 125.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 17 November 2023 from Singular Health Group Ltd. It announces a binding commitment from CG1 Ventures to take up a placement of $850,000 in shares. The text discusses the terms of the placement, payment schedule, and the strategic significance of the investment. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (4060 characters) and serves as an update on a financing event rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-11-16 English
Appointment of CFO 1 page 104.9KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 13 November 2023 regarding the appointment of a new Chief Financial Officer (CFO) for Singular Health Group Ltd. It contains biographical details and qualifications of the appointee and is authorized by the Board of Directors. There is no financial data, report, or detailed management discussion. The content clearly relates to a change in senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused solely on the appointment, confirming it is not a full report or announcement of a report publication.
2023-11-12 English
Results of Annual General Meeting 3 pages 291.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 10 November 2023, titled 'Results of Annual General Meeting'. It provides detailed voting results for resolutions put to shareholders at the AGM, including proxy votes, poll results, and outcomes for each resolution. The content focuses exclusively on the disclosure of voting results from the AGM, referencing specific resolutions and their outcomes. There is no indication that this document is the AGM presentation materials themselves, nor is it a full annual report or other financial report. The document is not a proxy solicitation or remuneration report but specifically the official results of shareholder votes at the AGM. Therefore, the document fits the category of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length (8452 characters) supports it being a detailed announcement rather than a brief notice or a full report. Confidence is high given the clear and explicit nature of the content.
2023-11-09 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.